Background Peri-intubation major adverse events (MAEs) are potentially preventable and
associated with poor patient outcomes. Critically ill patients intubated in Emergency …

After many years of uncertainty, malignant hyperthermia (MH) was eventually confirmed as a
human disease in 3 descendants by in vitro muscle biopsy. A 21-year-old engineering …

Study objective We aimed to study the association between propofol induction dose (mg/kg)
and pre-incision severe hypotension (Mean Arterial Pressure (MAP)≤ 55 mmHg) among …

Faced with a malignant hyperthermia crisis, the immediate access to sufficient dantrolene is
essential to achieve the best possible outcome for the patient. However, malignant …

Succinylcholine (Sch) is the only depolarizing neuromuscular blocking agent widely used for
rapid sequence induction in emergency rooms. Unfortunately, a variety of (sometimes lethal) …

Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by
volatile anesthetics and succinylcholine. Rarely, MH can occur after non-pharmacological …

Malignant hyperthermia (MH) is a potentially fatal inherited pharmacogenetic disorder
related to pathogenic variants in the RYR1, CACNA1S, or STAC3 genes. Early recognition …

Abstract Background Neuromuscular blocking agents (NMBAs) with a non-depolarising
mechanism of action carry the risk of postoperative residual paralysis and are associated …

When choosing medications and calculating doses in infants, children, and adolescents, it is
common to consider the patient's diagnosis, age, weight, and sometimes body surface area …

Abstract Background/Objectives Advanced age is associated with increased susceptibility to
acute adverse effects of propofol. The present study aimed to describe patterns of propofol …